175 related articles for article (PubMed ID: 33410653)
1. Cuboplex-Mediated Nonviral Delivery of Functional siRNA to Chinese Hamster Ovary (CHO) Cells.
Sarkar S; Tran N; Soni SK; Nasa Z; Drummond CJ; Conn CE
ACS Appl Mater Interfaces; 2021 Jan; 13(2):2336-2345. PubMed ID: 33410653
[TBL] [Abstract][Full Text] [Related]
2. Size-Dependent Encapsulation and Release of dsDNA from Cationic Lyotropic Liquid Crystalline Cubic Phases.
Sarkar S; Tran N; Soni SK; Conn CE; Drummond CJ
ACS Biomater Sci Eng; 2020 Aug; 6(8):4401-4413. PubMed ID: 33455184
[TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery.
Malamas AS; Gujrati M; Kummitha CM; Xu R; Lu ZR
J Control Release; 2013 Nov; 171(3):296-307. PubMed ID: 23796431
[TBL] [Abstract][Full Text] [Related]
4. Glycerol monooleate-based nanocarriers for siRNA delivery in vitro.
Zhen G; Hinton TM; Muir BW; Shi S; Tizard M; McLean KM; Hartley PG; Gunatillake P
Mol Pharm; 2012 Sep; 9(9):2450-7. PubMed ID: 22794355
[TBL] [Abstract][Full Text] [Related]
5. Metallo-Cubosomes: Zinc-Functionalized Cubic Nanoparticles for Therapeutic Nucleotide Delivery.
Tajik-Ahmadabad B; Chollet L; White J; Separovic F; Polyzos A
Mol Pharm; 2019 Mar; 16(3):978-986. PubMed ID: 30648870
[TBL] [Abstract][Full Text] [Related]
6. Cuboplexes: Topologically Active siRNA Delivery.
Kim H; Leal C
ACS Nano; 2015 Oct; 9(10):10214-26. PubMed ID: 26390340
[TBL] [Abstract][Full Text] [Related]
7. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
8. Aspects of nonviral gene therapy: correlation of molecular parameters with lipoplex structure and transfection efficacy in pyridinium-based cationic lipids.
Parvizi P; Jubeli E; Raju L; Khalique NA; Almeer A; Allam H; Manaa MA; Larsen H; Nicholson D; Pungente MD; Fyles TM
Int J Pharm; 2014 Jan; 461(1-2):145-56. PubMed ID: 24296044
[TBL] [Abstract][Full Text] [Related]
9. Biocompatible Nanovector of siRNA Consisting of Arginine-Based Cationic Lipid for Gene Knockdown in Cancer Cells.
Sánchez-Arribas N; Martínez-Negro M; Villar EM; Pérez L; Aicart E; Taboada P; Guerrero-Martínez A; Junquera E
ACS Appl Mater Interfaces; 2020 Aug; 12(31):34536-34547. PubMed ID: 32657573
[TBL] [Abstract][Full Text] [Related]
10. Microfluidics Synthesis of Gene Silencing Cubosomes.
Kim H; Sung J; Chang Y; Alfeche A; Leal C
ACS Nano; 2018 Sep; 12(9):9196-9205. PubMed ID: 30081623
[TBL] [Abstract][Full Text] [Related]
11. A QCM-D and SAXS Study of the Interaction of Functionalised Lyotropic Liquid Crystalline Lipid Nanoparticles with siRNA.
Tajik-Ahmadabad B; Mechler A; Muir BW; McLean K; Hinton TM; Separovic F; Polyzos A
Chembiochem; 2017 May; 18(10):921-930. PubMed ID: 28233412
[TBL] [Abstract][Full Text] [Related]
12. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
13. A systematic study of the effect of lipid architecture on cytotoxicity and cellular uptake of cationic cubosomes.
Pushpa Ragini S; Dyett BP; Sarkar S; Zhai J; White JF; Banerjee R; Drummond CJ; Conn CE
J Colloid Interface Sci; 2024 Jun; 663():82-93. PubMed ID: 38394820
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
15. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.
Sato Y; Hashiba K; Sasaki K; Maeki M; Tokeshi M; Harashima H
J Control Release; 2019 Feb; 295():140-152. PubMed ID: 30610950
[TBL] [Abstract][Full Text] [Related]
16. Identification of large channels in cationic PEGylated cubosome nanoparticles by synchrotron radiation SAXS and Cryo-TEM imaging.
Angelov B; Angelova A; Drechsler M; Garamus VM; Mutafchieva R; Lesieur S
Soft Matter; 2015 May; 11(18):3686-92. PubMed ID: 25820228
[TBL] [Abstract][Full Text] [Related]
17. Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells.
Zou S; Scarfo K; Nantz MH; Hecker JG
Int J Pharm; 2010 Apr; 389(1-2):232-43. PubMed ID: 20080162
[TBL] [Abstract][Full Text] [Related]
18. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
[TBL] [Abstract][Full Text] [Related]
19. Next generation macrocyclic and acyclic cationic lipids for gene transfer: Synthesis and in vitro evaluation.
Jubeli E; Maginty AB; Abdul Khalique N; Raju L; Abdulhai M; Nicholson DG; Larsen H; Pungente MD; Goldring WP
Bioorg Med Chem; 2015 Oct; 23(19):6364-78. PubMed ID: 26346671
[TBL] [Abstract][Full Text] [Related]
20. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
